Roper acquires Northern Digital

Roper Industries, Inc. (NYSE: ROP) today announced that it has completed the previously announced acquisition of Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications.  

Headquartered in Waterloo, Ontario, Canada, Northern Digital provides optical and electromagnetic measurement systems for medical and industrial applications.  NDI's technology is used in the growing fields of computer-assisted surgery, computer-assisted therapy and image-guided radiation treatment.  In addition, the Company's technology is utilized by advanced manufacturers for optical tracking and non-contact 3-D measurements.  

The all-cash transaction is valued at C$200 million and is expected to contribute more than C$20 million of EBITDA in the next twelve months.  Northern Digital will become part of Roper's medical platform within its Medical & Scientific Imaging segment.  The Company expects the acquisition will be accretive to the Company's earnings and cash flow.

"Northern Digital is an excellent addition to our medical platform with technology and applications to improve patient outcomes while increasing productivity for doctors and hospitals," said Brian Jellison, Roper's Chairman, President and CEO.  "We welcome the Northern Digital team to Roper and look forward to working together to enhance the value of the business."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare